Biostar Pharmaceuticals, Inc. (BSPM)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.91 Million | 5.87 Million | 3.31 Million | 8.9 Million | -3.58 Million | 8.77 Million |
| Net Income | -5.69 Million | -25.11 Million | 4.84 Million | 809.04 Thousand | -19.99 Million | - |
| Depreciation & Amortization | 1.14 Million | 2.32 Million | 3.08 Million | 2.78 Million | 1.82 Million | 885.11 Thousand |
| Deferred income taxes | 2.65 Million | 1.33 Million | -4.28 Million | 981.39 Thousand | -2.03 Million | - |
| Stock-based compensation | - | - | 2.02 Million | 757.38 Thousand | 821.7 Thousand | 1.72 Million |
| Change in working capital | 7.3 Million | 5.34 Million | -6.07 Million | 2.23 Million | 6.3 Million | -8.52 Million |
| Other non-cash items | -227.1 Thousand | 4.02 Million | 3.71 Million | 1.33 Million | 9.49 Million | 14.69 Million |
| Investing Cash Flow | -6.37 Million | -7.37 Million | -8.87 Million | -4.21 Million | -17.28 Million | -6.33 Million |
| Investments in PPE | - | -59.47 Thousand | -2.86 Million | -982.01 Thousand | -32.87 Thousand | -3.23 Million |
| Acquisitions | -6.37 Million | -8.12 Million | -4.88 Million | -3.87 Million | -823.88 Thousand | -3.1 Million |
| Investment purchases | - | -804.18 Thousand | - | - | - | - |
| Sales/Maturities of investments | - | 804.18 Thousand | - | - | - | - |
| Other Investing Activities | -6.37 Million | 804.18 Thousand | -1.12 Million | 645.75 Thousand | -16.43 Million | -3.11 Million |
| Financing Cash Flow | 1.41 Million | -160.83 Thousand | 6.95 Million | -6.45 Million | 5.54 Million | 787.11 Thousand |
| Debt repayment | -278.31 Thousand | -160.83 Thousand | -162.71 Thousand | -6.45 Million | -792.19 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.68 Million | - | 3.86 Million | - | - | - |
| Other Financing Activities | 1411.19 | -160.84 | 3.25 Million | -1.61 Million | 6.33 Million | - |
| Accounts receivables | 8.66 Million | 5.44 Million | -7.44 Million | 4.2 Million | 6.62 Million | -5.33 Million |
| Accounts payables | -1.08 Million | -602.95 Thousand | 573.1 Thousand | -1.44 Million | 3.19 Million | -2.85 Million |
| Inventory | 55.14 Thousand | 420.58 Thousand | 152.45 Thousand | 43.46 Thousand | 535.58 Thousand | -609.96 Thousand |
| Other working capital | -329.68 Thousand | 82.53 Thousand | 640.02 Thousand | -563.11 Thousand | -4.06 Million | -2.58 Million |
| Cash at beginning of period | 38.89 Thousand | 1.68 Million | 80.07 Thousand | 1.75 Million | 16.97 Million | 13.21 Million |
| Cash at end of period | 173.29 Thousand | 38.89 Thousand | 1.68 Million | 80.07 Thousand | 1.75 Million | 16.97 Million |
| Capital Expenditure | - | -59.47 Thousand | -2.86 Million | -982.01 Thousand | -32.87 Thousand | -3.23 Million |
| Effect of forex changes on cash | 188.67 Thousand | 14.89 Thousand | 218.47 Thousand | 80.21 Thousand | 114.43 Thousand | 539.7 Thousand |
| Net cash flow / Change in cash | 134.39 Thousand | -1.64 Million | 1.6 Million | -1.67 Million | -15.21 Million | 3.76 Million |
| Free Cash Flow | 4.91 Million | 5.81 Million | 441.41 Thousand | 7.92 Million | -3.61 Million | 5.54 Million |
| Breakdown | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 FY | 2016 Q4 | 2016 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -125.18 Thousand | -1.31 Million | -1.01 Million | -5.69 Million | 3.38 Million | -1.56 Million |
| Depreciation & Amortization | 300.24 Thousand | 281.77 Thousand | 297.82 Thousand | 1.14 Million | 229.14 Thousand | 400.53 Thousand |
| Deferred income taxes | - | - | - | 2.65 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -163.54 Thousand | 5.55 Million | 1.05 Million | 7.3 Million | 5.99 Million | 231.71 Thousand |
| Other non-cash items | -12.92 Thousand | -259.44 Thousand | -16.96 Thousand | -227.1 Thousand | -5.61 Million | 1.48 Million |
| Investing Cash Flow | -44.38 Thousand | -4.36 Million | - | -6.37 Million | -6.37 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | -44.38 Thousand | -4363.69 | - | -6.37 Million | -6378.14 | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -44.38 Thousand | - | - | -6.37 Million | - | - |
| Financing Cash Flow | - | - | - | 1.41 Million | 1.69 Million | 1887.00 |
| Debt repayment | - | - | - | -278.31 Thousand | -2701.00 | -1887.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 1.68 Million | - | - |
| Other Financing Activities | - | - | - | 1411.19 | 1.69 Million | 3774.00 |
| Accounts receivables | 69.26 Thousand | 5.57 Million | 1.23 Million | 8.66 Million | 7.06 Million | 107.42 Thousand |
| Accounts payables | -97.13 Thousand | 160.6 Thousand | -335.9 Thousand | -1.08 Million | -1.14 Million | 275.95 Thousand |
| Inventory | 32.00 | 7.00 | 3164.00 | 55.14 Thousand | 269.16 Thousand | -124.56 Thousand |
| Other working capital | -135.69 Thousand | -174.44 Thousand | 148.88 Thousand | -329.68 Thousand | -195.7 Thousand | -27.1 Thousand |
| Cash at beginning of period | 407.41 Thousand | 483.85 Thousand | 173.29 Thousand | 38.89 Thousand | 659.35 Thousand | 207.11 Thousand |
| Cash at end of period | 364.97 Thousand | 407.41 Thousand | 483.85 Thousand | 173.29 Thousand | 173.29 Thousand | 659.35 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 3355.00 | 21.41 Thousand | -10.56 Thousand | 188.67 Thousand | 198.25 Thousand | -107.06 Thousand |
| Net cash flow / Change in cash | -42.43 Thousand | -76.44 Thousand | 310.56 Thousand | 134.39 Thousand | -486.06 Thousand | 452.24 Thousand |
| Free Cash Flow | -1409.00 | 4.26 Million | 321.12 Thousand | 4.91 Million | 4 Million | 557.42 Thousand |
ANG
FMNB
RCOM
300173
ARQT
SMR-WT